Thailand has introduced the long-term resident visa (“LTR Visa”) to stimulate economic growth post the COVID-19 pandemic. The LTR Visa is offered to four categories of foreign nationals (“Eligible Foreigners”) who are wealthy global citizens (“WGC”), wealthy pensioners (“WP”), work-from-Thailand professionals (“WTP”), and highly-skilled professionals (“HSP”). Spouses and children (“Dependents”) of the LTR Visa holders… Read More
On 2nd July 2022 and 14th July 2022, the Ministry of Commerce (“MOC”) released the Letter No. Ka Ba Ya (Ma Sha) Pa Ka 2022-2023 (0199) and the Letter No. Ka Tha Ra (Mar Ta) Management/2022-2023 (0515) to prescribe the requirements for issuance of export license for export of rice, pulses, corn, various types of… Read More
On 13th July 2022, the Central Bank of Myanmar (“CBM”) issued the Letter No. FE-1/739 to cancel the exemption of the compulsory foreign currency conversion for companies registered with the Directorate of Investment and Company Administration (DICA) with 10% or more of foreign ownership (“Foreign Companies”). The CBM also issued the Letter No. FE-1/754 on… Read More
On 29th June 2022, the Central Bank of Myanmar (“CBM”) issued the Letter No. FE-1/643 for exemption of the foreign currency conversion requirements under the CBM Notification No. 12/2022 to exclude the following entities from the foreign currency conversion requirement: Representative Office of Woori Bank; Special Economic Zone Management Committees and their subordinated companies, such… Read More
Effective from 9th June 2022, Thailand has removed marijuana from the narcotics list (except for extracts that contain over 0.2% of tetrahydrocannabinol (THC) by weight) under the narcotics law. This change has created challenges for many Thai employers who want to prevent consumption of marijuana in their workplaces. Many employers consider revising their work rules… Read More
根据《麻醉品法B.E.2522》（公元1979年）的规定，公共卫生部关于第5类麻醉品规范的通知B.E.2565（公元2022年）于2022年6月9日生效，删除了第5类麻醉药品中大麻（大麻和火麻）及其提取物的大部分部分和形式，其中四氢大麻酚（THC）的含量不超过0.2重量%，公共卫生部于2022年6月16日发布了关于受管制的草药(大麻) 通知B. E. 2565，有效期为2022年6月17日至: (1) 根据《传统泰医药知识保护与促进法》E.2542（公元1999年），将大麻及其提取物归类为受管制草药； (2) 允许20岁以上的人拥有、使用、处理、储存、运输和分发大麻及其提取物，但以下情况除外： (a) 在公共场所吸食大麻; (b) 孕妇和哺乳妇女吸食大麻; (c) 向未满20岁的人、孕妇或哺乳妇女分发大麻; (3) 允许执业医生、泰国传统医生、泰国应用传统医生、中国传统医生和泰国民间医生为患者开出大麻及其提取物的处方；而且 (4) 允许上述第（3）项所述执业医师的患者持有、运输、处理、储存和使用大麻及其提取物作为处方药30天。 To see the archive of our past newsletters and articles please click here.